|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 205/04 | |
| C07D 413/12 | |||
| C07D 403/12 | |||
| C07D 401/12 | |||
| C07D 417/12 | |||
| A61K 31/397 | |||
| A61P 29/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 1781606 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05776965.5 |
| Date of filing the European patent application | 2005-08-09 | |
| (97) | Date of publication of the European application | 2007-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2009-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/008654 |
| Date | 2005-08-09 |
| (87) | Number | WO 2006/015854 |
| Date | 2006-02-16 |
| (30) | Number | Date | Country code |
| 0417801 | 2004-08-10 | GB |
| (72) |
LEGRAND, Darren Mark, GB
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
NOVARTIS-PHARMA GMBH, Brunner Strasse 59, 1230 Vienna, AT |
| (54) | AZETIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS |
| AZETIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS |